What is the Impact Factor of International Journal of Rheumatic Diseases?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of International Journal of Rheumatic Diseases is 2.00, ranking in quartile Q3 of Web of Science (SCIE).

Is International Journal of Rheumatic Diseases indexed in Web of Science or Scopus?

Yes, International Journal of Rheumatic Diseases is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.553 (Q3) and an H-index of 67.

Who publishes International Journal of Rheumatic Diseases and what is the Article Processing Charge (APC)?

International Journal of Rheumatic Diseases is published by Wiley-Blackwell Publishing Ltd. The estimated Article Processing Charge (APC) is approximately $3,053 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of International Journal of Rheumatic Diseases?

The official ISO-4 abbreviation of International Journal of Rheumatic Diseases is "INT J RHEUM DIS" with common acronym "aplar". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q3SCImago #10,734Hybrid

International Journal of Rheumatic Diseases

Acronym:aplar

•

Abbreviation (ISO):INT J RHEUM DIS

•

Identifier (ISSN):1756-1841(Print)/1756-185X(Online)

•

Publisher:Wiley-Blackwell Publishing Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

2– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for International Journal of Rheumatic Diseases

WoS Q3

Annual Impact Factor Metric

Current (2026):2

Scopus SJR & RankScopus Q3

0.553

#10,734

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

67 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate20.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

158articles/year

17.22% Gold OA•79.08% Original Research

Aims & Scope

The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.

Topics Covered (Recognized by AI)

Medicine94.3%Internal medicine77.4%Biology73.1%Pathology65.6%Immunology52.5%Surgery42.4%Disease36.7%Genetics34%Psychology31.2%Chemistry27.2%Psychiatry26.9%Radiology25.9%Rheumatoid arthritis25.9%Biochemistry25%Mathematics24.3%Endocrinology23.7%Statistics21.6%

Primary Research Areas

Rheumatology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

RHEUMATOLOGY

Rank36/58

IndexSCIE

JCISCIE2026

RHEUMATOLOGY

Rank37/58

IndexSCIE

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRSCIE	36/58	Q3
RHEUMATOLOGY	JCISCIE	37/58	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2

Articles / Year520

Total Citations48

2025

IF2

Articles / Year500

Total Citations628

2024

IF2.4

Articles / Year490

Total Citations1,057

2023

IF2.5

Articles / Year495

Total Citations2,012

2022

IF2.558

Articles / Year274

Total Citations2,019

Year	Impact Factor	Articles / Year	Total Citations
2026	2	520	48
2025	2	500	628
2024	2.4	490	1,057
2023	2.5	495	2,012
2022	2.558	274	2,019
2021	2.454	241	2,380
2020	1.98	272	3,363
2019	1.938	324	4,172
2018	2.423	232	4,331
2017	—	262	6,084
2016	—	193	2,954
2015	—	260	5,235

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,734Scopus Q3SCImago Profile

Scopus Coverage:2008-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.553

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.29

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,053 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,661

3-Year Documents1,170

Citable Documents716

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

RheumatologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 20.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

International Journal of Rheumatic Diseases (acronym: aplar, abbr: INT J RHEUM DIS, ISSN: 1756-1841) is a peer-reviewed international scholarly journal in the field of RHEUMATOLOGY, published by Wiley-Blackwell Publishing Ltd in Australia since 2008. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.553 (Q3), an H-index of 67.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 158 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,053 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.